0001749990-22-000002.txt : 20221104 0001749990-22-000002.hdr.sgml : 20221104 20221104123148 ACCESSION NUMBER: 0001749990-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221104 DATE AS OF CHANGE: 20221104 EFFECTIVENESS DATE: 20221104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Paragon Biosciences Emalex Capital, Inc. CENTRAL INDEX KEY: 0001749990 IRS NUMBER: 831197670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463914 FILM NUMBER: 221361250 BUSINESS ADDRESS: STREET 1: 1033 SKOKIE BOULEVARD STREET 2: SUITE #600 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: (847) 715-0606 MAIL ADDRESS: STREET 1: 1033 SKOKIE BOULEVARD STREET 2: SUITE #600 CITY: NORTHBROOK STATE: IL ZIP: 60062 D 1 primary_doc.xml X0708 D LIVE 0001749990 Paragon Biosciences Emalex Capital, Inc. 1033 SKOKIE BOULEVARD SUITE #600 NORTHBROOK IL ILLINOIS 60062 (847) 715-0606 DELAWARE None None Corporation true 2018 Patrick J. Morris c/o Paragon Biosciences Emalex Capital 330 N. Wabash, Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Jeffrey Aronin c/o Paragon Biosciences Emalex Capital 330 N. Wabash, Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Director Antonio Gracias c/o Valor Emalex Holdings, LLC 875 N. Michigan Ave., Ste. 3214 Chicago IL ILLINOIS 60611 Director Darien Parhad c/o Paragon Biosciences Emalex Capital 330 N. Wabash, Suite 3500 Chicago IL ILLINOIS 60611 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-10-21 true true false 8372 Paragon Health Capital, LLC 300729 None None 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 CT CONNECTICUT FL FLORIDA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA false 250000000 185000000 65000000 Total Offering Amount includes $65,000,000, the offering of which is subject to the achievement by the Company of certain milestones; Total Amount Sold includes the conversion of $25,000,000 of convertible notes previously issued to investors. false 42 4277435 0 0 false Paragon Biosciences Emalex Capital, Inc. /s/ Patrick J. Morris Patrick J. Morris President and Secretary 2022-11-04